Literature DB >> 21679768

Cerebral cortex demyelination and oligodendrocyte precursor response to experimental autoimmune encephalomyelitis.

Francesco Girolamo1, Giovanni Ferrara, Maurizio Strippoli, Marco Rizzi, Mariella Errede, Maria Trojano, Roberto Perris, Luisa Roncali, Maria Svelto, Tiziana Mennini, Daniela Virgintino.   

Abstract

Experimentally induced autoimmune encephalomyelitis (EAE) in mice provides an animal model that shares many features with human demyelinating diseases such as multiple sclerosis (MS). To what extent the cerebral cortex is affected by the process of demyelination and how the corollary response of the oligodendrocyte lineage is explicated are still not completely known aspects of EAE. By performing a detailed in situ analysis of expression of myelin and oligodendrocyte markers we have identified areas of subpial demyelination in the cerebral cortex of animals with conventionally induced EAE conditions. On EAE-affected cerebral cortices, the distribution and relative abundance of cells of the oligodendrocyte lineage were assessed and compared with control mouse brains. The analysis demonstrated that A2B5(+) glial restricted progenitors (GRPs) and NG2(+)/PDGFR-α(+) oligodendrocyte precursor cells (OPCs) were increased in number during "early" disease, 20 days post MOG immunization, whereas in the "late" disease, 39 days post-immunization, they were strongly diminished, and there was an accompanying reduction in NG2(+)/O4(+) pre-oligodendrocytes and GST-π mature oligodendrocytes. These results, together with the observed steady-state amount of NG2(-)/O4(+) pre-myelinating oligodendrocytes, suggested that oligodendroglial precursors attempted to compensate for the progressive loss of myelin, although these cells appeared to fail to complete the last step of their differentiation program. Our findings confirm that this chronic model of EAE reproduces the features of neocortex pathology in progressive MS and suggest that, despite the proliferative response of the oligodendroglial precursors, the failure to accomplish final differentiation may be a key contributing factor to the impaired remyelination that characterizes these demyelinating conditions.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21679768     DOI: 10.1016/j.nbd.2011.05.021

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  24 in total

1.  Effects of sleep and wake on oligodendrocytes and their precursors.

Authors:  Michele Bellesi; Martha Pfister-Genskow; Stephanie Maret; Sunduz Keles; Giulio Tononi; Chiara Cirelli
Journal:  J Neurosci       Date:  2013-09-04       Impact factor: 6.167

2.  Effect of Bushen Yisui Capsule () on oligodendrocyte lineage genes 1 and 2 in mice with experimental autoimmune encephalomyelitis.

Authors:  Tao Yang; Qi Zheng; Hui Zhao; Qiu-Xia Zhang; Ming Li; Fang Qi; Kang-Ning Li; Ling Fang; Lei Wang; Yong-Ping Fan
Journal:  Chin J Integr Med       Date:  2016-02-26       Impact factor: 1.978

3.  Autoantibodies against myelin sheath and S100β are associated with cognitive dysfunction in patients with rheumatoid arthritis.

Authors:  Talita Siara Almeida Baptista; Laura Esteves Petersen; Julia K Molina; Tatiana de Nardi; Andréa Wieck; Aline do Prado; Deise Marcela Piovesan; Mauro Keisermann; Rodrigo Grassi-Oliveira; Moisés Evandro Bauer
Journal:  Clin Rheumatol       Date:  2017-06-27       Impact factor: 2.980

4.  Copper chelation and autoimmunity differentially impact myelin in the hippocampal-prefrontal circuit.

Authors:  Mara Nickel; Farida Eid; Peter Jukkola; Chen Gu
Journal:  J Neuroimmunol       Date:  2019-06-20       Impact factor: 3.478

Review 5.  Laminin regulates oligodendrocyte development and myelination.

Authors:  Minkyung Kang; Yao Yao
Journal:  Glia       Date:  2021-11-12       Impact factor: 7.452

Review 6.  Glia-neuron interactions in neurological diseases: Testing non-cell autonomy in a dish.

Authors:  Kathrin Meyer; Brian K Kaspar
Journal:  Brain Res       Date:  2016-01-09       Impact factor: 3.252

7.  CXCR7 antagonism prevents axonal injury during experimental autoimmune encephalomyelitis as revealed by in vivo axial diffusivity.

Authors:  Lillian Cruz-Orengo; Ying-Jr Chen; Joong Hee Kim; Denise Dorsey; Sheng-Kwei Song; Robyn S Klein
Journal:  J Neuroinflammation       Date:  2011-12-06       Impact factor: 8.322

8.  Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsets.

Authors:  Francesco Girolamo; Alice Dallatomasina; Marco Rizzi; Mariella Errede; Thomas Wälchli; Maria Teresa Mucignat; Karl Frei; Luisa Roncali; Roberto Perris; Daniela Virgintino
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

Review 9.  Glial restricted precursor cells in central nervous system disorders: Current applications and future perspectives.

Authors:  Joana Martins-Macedo; Angelo C Lepore; Helena S Domingues; António J Salgado; Eduardo D Gomes; Luísa Pinto
Journal:  Glia       Date:  2020-10-14       Impact factor: 7.452

10.  Central canal ependymal cells proliferate extensively in response to traumatic spinal cord injury but not demyelinating lesions.

Authors:  Steve Lacroix; Laura K Hamilton; Alexandre Vaugeois; Stéfanny Beaudoin; Christian Breault-Dugas; Isabelle Pineau; Sébastien A Lévesque; Catherine-Alexandra Grégoire; Karl J L Fernandes
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.